tiprankstipranks
Guided Therapeutics Inc (GTHP)
OTHER OTC:GTHP
US Market

Guided Therapeutics (GTHP) Income Statement

28 Followers

Guided Therapeutics Income Statement

Last quarter (Q4 2025), Guided Therapeutics's total revenue was $-177.00K, a decrease of -17800.00% from the same quarter last year. In Q4, Guided Therapeutics's net income was $-1.37M. See Guided Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 7.00K$ 98.00K$ 13.00K$ 81.00K
Gross Profit
$ 571.00K$ 2.00K$ 36.00K$ -68.00K$ 20.00K
Operating Expenses
$ 2.94M$ 2.11M$ 3.49M$ 3.27M$ 2.38M
Depreciation and Amortization
$ 0.00$ 95.00K$ 85.00K$ 72.00K$ 1.00K
EBITDA
$ -2.37M$ -1.94M$ -3.13M$ -3.69M$ -919.00K
Operating Income
$ -2.37M$ -2.11M$ -3.46M$ -3.33M$ -2.36M
Other Income/Expenses
$ -824.00K$ -309.00K$ -32.00K$ -1.01M$ 292.00K
Pretax Income
$ -3.20M$ -2.42M$ -3.49M$ -4.34M$ -2.07M
Net Income
$ -3.35M$ -2.42M$ -3.49M$ -4.34M$ -2.07M
Per Share Metrics
Basic EPS
$ -0.04$ -0.05$ -0.07$ -0.15$ -0.18
Diluted EPS
$ -0.04$ -0.05$ -0.07$ -0.15$ -0.18
Weighted Average Shares Outstanding
78.41M 57.34M 51.13M 32.51M 13.38M
Weighted Average Shares Outstanding (Diluted)
78.41M 57.34M 51.13M 32.51M 13.38M
Currency in USD

Guided Therapeutics Earnings and Revenue History